Viking Therapeutics, Inc. (0VQA.L) LSE

44.00

+1.94(+4.61%)

Updated at August 19 08:43AM

Currency In USD

Valuation

Market Cap4.39B
Enterprise Value4.36B
P/E Ratio-27.51
PEG Ratio0.83
Price/Sales Ratio0
Price/Book Ratio5.93
Enterprise/Revenue0
Enterprise/EBITDA-22.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.2

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-109.52M
Net Income-109.96M
Diluted EPS-1.01

Balance Sheet

Total Cash33.88M
Total Cash/Share0.3
Total Debt878,000
Total Debt/Equity0
Current Ratio25.86
Book Value Per Share7.09

Price History

52-Week Change-27.48
52-Week High99.3
52-Week Low8.79
Moving Average 50 Days38.31
Moving Average 200 Days21.29

Statistics

Average Volume10,491
Shares Outstanding112.45M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A